英科医疗（300677）2月12日主力资金净卖出2552.32万元

Core Viewpoint - As of February 12, 2026, Yingke Medical (300677) closed at 40.08 yuan, down 2.6%, with a turnover rate of 1.46% and a trading volume of 68,000 hands, amounting to a transaction value of 274 million yuan [1] Group 1: Market Performance - On February 12, 2026, the net outflow of main funds was 25.52 million yuan, accounting for 9.31% of the total transaction value, while retail investors saw a net inflow of 31.69 million yuan, representing 11.56% of the total transaction value [1] - Over the past five days, the stock has experienced fluctuations in net fund flows, with notable outflows on February 9 and February 12, and a net inflow from retail investors on February 12 [2] Group 2: Financing and Margin Trading - On February 12, 2026, the financing buy-in was 19.75 million yuan, while the financing repayment was 28.53 million yuan, resulting in a net repayment of 8.78 million yuan [2] - The margin trading balance stood at 503 million yuan, with a short selling volume of 3,100 shares and a remaining short selling balance of 9.41 million yuan [3] Group 3: Company Financials and Industry Comparison - Yingke Medical's total market capitalization is 26.207 billion yuan, with a net asset value of 18.467 billion yuan and a net profit of 924 million yuan, ranking 8th, 4th, and 7th respectively in the medical device industry [5] - The company reported a year-on-year revenue increase of 4.6% to 7.425 billion yuan for the first three quarters of 2025, with a net profit increase of 34.47% to 924 million yuan [5] - The gross profit margin is 23.7%, which is significantly lower than the industry average of 51.01%, indicating potential areas for improvement [5]